InvestorsHub Logo
Followers 233
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Friday, 12/15/2017 12:26:37 PM

Friday, December 15, 2017 12:26:37 PM

Post# of 429037
Updated Appeal Docket: Amarin appeal and request for writ of mandamus review of ITC abuse of discretion is hot...

It is clear by the rapid filings of the "proposed inventors" they fear an ITC investigation; what do they have to hide? Amarin has already submitted the labeling evidence to ITC, ITC ignored it, Amarin appropriately requested mandamus for ITC abuse of discretion. Reading 20 and 21 you can feel the fear.....

Proposed Inventors have now overplayed their cards, I wouldn't be surprised to see Amarin and ITC file a joint motion for mandamus review.

BB


12/05/2017 12 Note to file: The following cases are associated: 18-1247 Lead with 18-114 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [480417] [18-1247, 18-114]
12/11/2017 13 Entry of appearance for Mark S. Davies as principal counsel for Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products, LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC. Service: 12/11/2017 by email. [481668]
12/11/2017 14 MOTION of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC for leave to intervene. Any response is due within 10 days of service [Consent: opposed]. Service: 12/11/2017 by email. [481675]
12/11/2017 15 MOTION of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC to set briefing schedule. Any response is due within 10 days of service [Consent: opposed]. Service: 12/11/2017 by email. [481678]
12/13/2017 16 RESPONSE of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to the motion for leave to intervene [14]. Service: 12/13/2017 by email. [482453]
12/13/2017 17 RESPONSE of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to the motion to set briefing schedule [15]. Service: 12/13/2017 by email. [482455]
12/14/2017 18 RESPONSE of Appellee ITC to the motion to set briefing schedule [15]. Service: 12/14/2017 by email. [482582]
12/14/2017 19 RESPONSE of Appellee ITC to the motion for leave to intervene [14]. Service: 12/14/2017 by email. [482586]
12/15/2017 20 REPLY of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC to response filed by Appellants in 18-1247 , Doc. No [16], response filed by Appellee in 18-1247 , Doc. No [19]. Service: 12/15/2017 by email. [482924]
12/15/2017 21 REPLY of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC to response filed by Appellants in 18-1247 , Doc. No [17], response filed by Appellee in 18-1247 , Doc. No [18]. Service: 12/15/2017 by email. [482926]

Mr. McGee, don't make me angry. You wouldn't like me when I'm angry---David Banner

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News